MENU
+Compare
IBBQ
ETF ticker: NASDAQ
AS OF
Feb 21, 01:20 PM (EDT)
Price
$23.05
Change
+$0.08 (+0.35%)
Net Assets
40.47M

IBBQ stock forecast, quote, news & analysis

Category: @Health
IBBQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for IBBQ with price predictions
Feb 20, 2025

IBBQ in upward trend: price may ascend as a result of having broken its lower Bollinger Band on February 11, 2025

IBBQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 31 cases where IBBQ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for IBBQ just turned positive on February 18, 2025. Looking at past instances where IBBQ's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

IBBQ moved above its 50-day moving average on February 12, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IBBQ crossed bullishly above the 50-day moving average on January 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IBBQ advanced for three days, in of 231 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 144 cases where IBBQ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IBBQ moved out of overbought territory on February 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator moved out of overbought territory. In of the 14 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on February 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IBBQ as a result. In of 64 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBBQ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Nasdaq Biotechnology Index ®. The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Nasdaq Biotechnology ETF ETF is 6.95B. The market cap for tickers in the group ranges from 30.34M to 208.98B. AZN holds the highest valuation in this group at 208.98B. The lowest valued company is MRNS at 30.34M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was 40%. For the same ETF, the average monthly price growth was 107%, and the average quarterly price growth was 316%. EDIT experienced the highest price growth at 67%, while CABA experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Invesco Nasdaq Biotechnology ETF ETF was 0%. For the same stocks of the ETF, the average monthly volume growth was 3% and the average quarterly volume growth was 73%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 77
Price Growth Rating: 59
SMR Rating: 88
Profit Risk Rating: 83
Seasonality Score: -53 (-100 ... +100)
View a ticker or compare two or three
IBBQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
PowerShares Exchange-Traded Fund Tr II301 West Roosevelt RoadWheaton
Phone
N/A
Web
www.invescopowershares.com